
AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032
Description
AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032
The global AI in genomics market size is expected to reach USD 16,757.95 million by 2032, according to a new study by Polaris Market Research. The report “AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The substantial financial support required to generate genomic data plays a crucial role in driving the market's growth. Institutions like the National Human Genome Research Institute (NHGRI) contribute significantly to this growth by allocating substantial funding, with an annual investment of over $125 million, to support diverse genomic data science initiatives. This financial backing enables researchers and organizations to generate and accumulate extensive genomic datasets. As the volume of genomic data increases, the demand for AI technologies, including machine learning and deep learning algorithms, rises to effectively analyze and derive insights from this vast amount of information.
The collaboration between private & commercial cloud and governmental & public entities, such as the National Institutes of Health (NIH) through initiatives like STRIDES, drives the market's growth. These collaborative initiatives support the storage and computing infrastructure to host genomic data. They provide scalable and secure platforms to handle the large volumes of genomic data generated in genomics research. Additionally, they prioritize implementing robust security and privacy measures to safeguard sensitive human genomic data.
AI in Genomics Market Report Highlights
Software segment is anticipated to witness faster growth in the coming years due to the rise in genomic data.
Machine Learning segment accounted for the largest revenue share owing to the increased volume and complexity of data.
Genome Sequencing segment is projected to experience the largest revenue share due to the advancements in DNA sequencing technologies.
Precision Medicine is expected to witness significant growth rate due to growing personalized treatment approaches.
Pharmaceuticals and Biotech Companies are expected to grow at a substantial rate due to accelerated drug discovery.
North America is projected to witness largest revenue share owing to the rise in government initiatives to promote healthcare. While Europe is expected to grow a larger revenue share owing to the encouragement from the governments by funding the projects.
The global players include Google DeepMind, QIAGEN Bioinformatics, SOPHiA DDM, WuXi NextCODE, Genuity Science, Lifebit, Envisagenics, ZS Genetics, MedGenome, Cypher Genomics, PierianDx, Bluebee, Repositive, Precision for Medicine, Shivom & Bluegnome.
Polaris Market Research has segmented the AI in Genomics market report based on offering, technology, functionality, application, end user and region:
AI in Genomics, Offering Outlook (Revenue - USD Million, 2019 - 2032)
Software
Services
AI in Genomics, Technology Outlook (Revenue - USD Million, 2019 - 2032)
Machine Learning
Deep Learning
Supervised Learning
Unsupervised Learning
Reinforcement Learning
Other Machine Learning Technologies
Other Technologies
AI in Genomics, Functionality Outlook (Revenue - USD Million, 2019 - 2032)
Genome Sequencing
Gene Editing
Clinical Workflows
Predictive Genetic Testing & Preventive Medicine
AI in Genomics, Application Outlook (Revenue - USD Million, 2019 - 2032)
Diagnostics
Drug Discovery & Development
Precision Medicine
Agriculture & Animal Research
Other Applications
AI in Genomics, End User Outlook (Revenue - USD Million, 2019 - 2032)
Pharmaceutical and Biotech Companies
Healthcare Providers
Research Centres, Academic Institutes and Government Organization
Other End Users
AI in Genomics, Regional Outlook (Revenue - USD Million, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
115 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global AI in Genomics Market Insights
- 4.1. AI in Genomics – Industry Snapshot
- 4.2. AI in Genomics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Exponential growth of biomedical research projects
- 4.2.1.2. Technological advancements and computational power
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Data quality and availability
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. AI in Genomics Industry Trends
- 4.6. COVID-19 Impact Analysis
- 5. Global AI in Genomics Market, by Offering
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 5.3. Software
- 5.3.1. Global AI in Genomics Market, by Software, by Region, 2019-2032 (USD Million)
- 5.4. Services
- 5.4.1. Global AI in Genomics Market, by Services, by Region, 2019-2032 (USD Million)
- 6. Global AI in Genomics Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 6.3. Machine Learning
- 6.3.1. Global AI in Genomics Market, by Machine Learning, by Region, 2019-2032 (USD Million)
- 6.3.2. Deep Learning
- 6.3.2.1. Global AI in Genomics Market, by Deep Learning, by Region, 2019-2032 (USD Million)
- 6.3.3. Supervised Learning
- 6.3.3.1. Global AI in Genomics Market, by Supervised Learning, by Region, 2019-2032 (USD Million)
- 6.3.4. Unsupervised Learning
- 6.3.4.1. Global AI in Genomics Market, by Unsupervised Learning, by Region, 2019-2032 (USD Million)
- 6.3.5. Reinforcement Learning
- 6.3.5.1. Global AI in Genomics Market, by Reinforcement Learning, by Region, 2019-2032 (USD Million)
- 6.3.6. Other Machine Learning Technologies
- 6.3.6.1. Global AI in Genomics Market, by Other Machine Learning Technologies, by Region, 2019-2032 (USD Million)
- 6.4. Others Technologies
- 6.4.1. Global AI in Genomics Market, by Others Technologies, by Region, 2019-2032 (USD Million)
- 7. Global AI in Genomics Market, by Functionality
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 7.3. Genome Sequencing
- 7.3.1. Global AI in Genomics Market, by Genome Sequencing, by Region, 2019-2032 (USD Million)
- 7.4. Gene Editing
- 7.4.1. Global AI in Genomics Market, by Gene Editing, by Region, 2019-2032 (USD Million)
- 7.5. Clinical Workflows
- 7.5.1. Global AI in Genomics Market, by Clinical Workflows, by Region, 2019-2032 (USD Million)
- 7.6. Predictive Genetic Testing & Preventive Medicine
- 7.6.1. Global AI in Genomics Market, by Predictive Genetic Testing & Preventive Medicine, by Region, 2019-2032 (USD Million)
- 8. Global AI in Genomics Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 8.3. Diagnostics
- 8.3.1. Global AI in Genomics Market, by Diagnostics, by Region, 2019-2032 (USD Million)
- 8.4. Drug Discovery & Development
- 8.4.1. Global AI in Genomics Market, by Drug Discovery & Development, by Region, 2019-2032 (USD Million)
- 8.5. Precision Medicine
- 8.5.1. Global AI in Genomics Market, by Precision Medicine, by Region, 2019-2032 (USD Million)
- 8.6. Agriculture & Animal Research
- 8.6.1. Global AI in Genomics Market, by Agriculture & Animal Research, by Region, 2019-2032 (USD Million)
- 8.7. Other Applications
- 8.7.1. Global AI in Genomics Market, by Other Applications, by Region, 2019-2032 (USD Million)
- 9. Global AI in Genomics Market, by End User
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 9.3. Pharmaceutical and Biotech Companies
- 9.3.1. Global AI in Genomics Market, by Pharmaceutical and Biotech Companies, by Region, 2019-2032 (USD Million)
- 9.4. Healthcare Providers
- 9.4.1. Global AI in Genomics Market, by Healthcare Providers, by Region, 2019-2032 (USD Million)
- 9.5. Research Centres, Academic Institutes and Government Organization
- 9.5.1. Global AI in Genomics Market, by Research Centres, Academic Institutes and Government Organization, by Region, 2019-2032 (USD Million)
- 9.6. Other End Users
- 9.6.1. Global AI in Genomics Market, by Other End Users, by Region, 2019-2032 (USD Million)
- 10. Global AI in Genomics Market, by Geography
- 10.1. Key findings
- 10.2. Introduction
- 10.2.1. AI in Genomics Market Assessment, By Geography, 2019-2032 (USD Million)
- 10.3. AI in Genomics Market – North America
- 10.3.1. North America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.3.2. North America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.3.3. North America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.3.4. North America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.3.5. North America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.3.6. AI in Genomics Market – U.S.
- 10.3.6.1. U.S.: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.3.6.2. U.S.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.3.6.3. U.S.: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.3.6.4. U.S.: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.3.6.5. U.S.: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.3.7. AI in Genomics Market – Canada
- 10.3.7.1. Canada: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.3.7.2. Canada.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.3.7.3. Canada: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.3.7.4. Canada: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.3.7.5. Canada: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4. AI in Genomics Market – Europe
- 10.4.1. Europe: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.2. Europe.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.3. Europe: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.4. Europe: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.5. Europe: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.6. AI in Genomics Market – UK
- 10.4.6.1. UK: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.6.2. UK.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.6.3. UK: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.6.4. UK: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.6.5. UK: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.7. AI in Genomics Market – France
- 10.4.7.1. France: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.7.2. France.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.7.3. France: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.7.4. France: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.7.5. France: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.8. AI in Genomics Market – Germany
- 10.4.8.1. Germany: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.8.2. Germany.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.8.3. Germany: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.8.4. Germany: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.8.5. Germany: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.9. AI in Genomics Market – Italy
- 10.4.9.1. Italy: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.9.2. Italy.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.9.3. Italy: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.9.4. Italy: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.9.5. Italy: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.10. AI in Genomics Market – Spain
- 10.4.10.1. Spain: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.10.2. Spain.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.10.3. Spain: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.10.4. Spain: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.10.5. Spain: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.11. AI in Genomics Market – Netherlands
- 10.4.11.1. Netherlands: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.11.2. Netherlands.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.11.3. Netherlands: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.11.4. Netherlands: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.11.5. Netherlands: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.12. AI in Genomics Market – Russia
- 10.4.12.1. Russia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.12.2. Russia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.12.3. Russia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.12.4. Russia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.12.5. Russia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5. AI in Genomics Market – Asia Pacific
- 10.5.1. Asia Pacific: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.2. Asia Pacific.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.3. Asia Pacific: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.4. Asia Pacific: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.5. Asia Pacific: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.6. AI in Genomics Market – China
- 10.5.6.1. China: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.6.2. China.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.6.3. China: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.6.4. China: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.6.5. China: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.7. AI in Genomics Market – India
- 10.5.7.1. India: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.7.2. India.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.7.3. India: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.7.4. India: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.7.5. India: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.8. AI in Genomics Market – Japan
- 10.5.8.1. Japan: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.8.2. Japan.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.8.3. Japan: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.8.4. Japan: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.8.5. Japan: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.9. AI in Genomics Market – Malaysia
- 10.5.9.1. Malaysia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.9.2. Malaysia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.9.3. Malaysia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.9.4. Malaysia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.9.5. Malaysia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.10. AI in Genomics Market – Indonesia
- 10.5.10.1. Indonesia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.10.2. Indonesia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.10.3. Indonesia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.10.4. Indonesia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.10.5. Indonesia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.11. AI in Genomics Market – South Korea
- 10.5.11.1. South Korea: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.11.2. South Korea.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.11.3. South Korea: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.11.4. South Korea: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.11.5. South Korea: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6. AI in Genomics Market – Middle East & Africa
- 10.6.1. Middle East & Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.2. Middle East & Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.3. Middle East & Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.4. Middle East & Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.5. Middle East & Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6.6. AI in Genomics Market – Saudi Arabia
- 10.6.6.1. Saudi Arabia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.6.2. Saudi Arabia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.6.3. Saudi Arabia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.6.4. Saudi Arabia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.6.5. Saudi Arabia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6.7. AI in Genomics Market – UAE
- 10.6.7.1. UAE: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.7.2. UAE.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.7.3. UAE: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.7.4. UAE: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.7.5. UAE: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6.8. AI in Genomics Market – Israel
- 10.6.8.1. Israel: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.8.2. Israel.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.8.3. Israel: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.8.4. Israel: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.8.5. Israel: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6.9. AI in Genomics Market – South Africa
- 10.6.9.1. South Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.9.2. South Africa.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.9.3. South Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.9.4. South Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.9.5. South Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.7. AI in Genomics Market – Latin America
- 10.7.1. Latin America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.7.2. Latin America.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.7.3. Latin America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.7.4. Latin America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.7.5. Latin America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.7.6. AI in Genomics Market – Mexico
- 10.7.6.1. Mexico: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.7.6.2. Mexico.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.7.6.3. Mexico: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.7.6.4. Mexico: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.7.6.5. Mexico: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.7.7. AI in Genomics Market – Brazil
- 10.7.7.1. Brazil: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.7.7.2. Brazil.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.7.7.3. Brazil: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.7.7.4. Brazil: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.7.7.5. Brazil: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.7.8. AI in Genomics Market – Argentina
- 10.7.8.1. Argentina: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.7.8.2. Argentina.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.7.8.3. Argentina: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.7.8.4. Argentina: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.7.8.5. Argentina: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
- 12. Company Profiles
- 12.1. Google DeepMind
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. IBM Watson Health
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. BenevolentAI
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Tempus
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Freenome
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Sophia Genetics
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. 23andMe
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. DNAnexus
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Recursion Pharmaceuticals
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Verge Genomics
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. PathAI
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. GNS Healthcare
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
- 12.13. Freenome
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development
- 12.14. Fabric Genomics
- 12.14.1. Company Overview
- 12.14.2. Financial Performance
- 12.14.3. Product Benchmarking
- 12.14.4. Recent Development
- 12.15. Foundation Medicine
- 12.15.1. Company Overview
- 12.15.2. Financial Performance
- 12.15.3. Product Benchmarking
- 12.15.4. Recent Development
- 12.16. SOPHiA GENETICS
- 12.16.1. Company Overview
- 12.16.2. Financial Performance
- 12.16.3. Product Benchmarking
- 12.16.4. Recent Development
- 12.17. Nebula Genomics
- 12.17.1. Company Overview
- 12.17.2. Financial Performance
- 12.17.3. Product Benchmarking
- 12.17.4. Recent Development
- 12.18. CytoReason
- 12.18.1. Company Overview
- 12.18.2. Financial Performance
- 12.18.3. Product Benchmarking
- 12.18.4. Recent Development
- 12.19. Genoox
- 12.19.1. Company Overview
- 12.19.2. Financial Performance
- 12.19.3. Product Benchmarking
- 12.19.4. Recent Development
- 12.20. Genalice
- 12.20.1. Company Overview
- 12.20.2. Financial Performance
- 12.20.3. Product Benchmarking
- 12.20.4. Recent Development
- 12.21. Deep Genomics
- 12.21.1. Company Overview
- 12.21.2. Financial Performance
- 12.21.3. Product Benchmarking
- 12.21.4. Recent Development
- 12.22. Owkin
- 12.22.1. Company Overview
- 12.22.2. Financial Performance
- 12.22.3. Product Benchmarking
- 12.22.4. Recent Development
- 12.23. Genialis
- 12.23.1. Company Overview
- 12.23.2. Financial Performance
- 12.23.3. Product Benchmarking
- 12.23.4. Recent Development
- 12.24. Gencove
- 12.24.1. Company Overview
- 12.24.2. Financial Performance
- 12.24.3. Product Benchmarking
- 12.24.4. Recent Development
- 12.25. Helix
- 12.25.1. Company Overview
- 12.25.2. Financial Performance
- 12.25.3. Product Benchmarking
- 12.25.4. Recent Development
- 12.26. QIAGEN Bioinformatics
- 12.26.1. Company Overview
- 12.26.2. Financial Performance
- 12.26.3. Product Benchmarking
- 12.26.4. Recent Development
- 12.27. SOPHiA DDM
- 12.27.1. Company Overview
- 12.27.2. Financial Performance
- 12.27.3. Product Benchmarking
- 12.27.4. Recent Development
- 12.28. WuXi NextCODE
- 12.28.1. Company Overview
- 12.28.2. Financial Performance
- 12.28.3. Product Benchmarking
- 12.28.4. Recent Development
- 12.29. Genuity Science
- 12.29.1. Company Overview
- 12.29.2. Financial Performance
- 12.29.3. Product Benchmarking
- 12.29.4. Recent Development
- 12.30. Lifebit
- 12.30.1. Company Overview
- 12.30.2. Financial Performance
- 12.30.3. Product Benchmarking
- 12.30.4. Recent Development
- 12.31. Envisagenics
- 12.31.1. Company Overview
- 12.31.2. Financial Performance
- 12.31.3. Product Benchmarking
- 12.31.4. Recent Development
- 12.32. ZS Genetics
- 12.32.1. Company Overview
- 12.32.2. Financial Performance
- 12.32.3. Product Benchmarking
- 12.32.4. Recent Development
- 12.33. MedGenome
- 12.33.1. Company Overview
- 12.33.2. Financial Performance
- 12.33.3. Product Benchmarking
- 12.33.4. Recent Development
- 12.34. Cypher Genomics
- 12.34.1. Company Overview
- 12.34.2. Financial Performance
- 12.34.3. Product Benchmarking
- 12.34.4. Recent Development
- 12.35. PierianDx
- 12.35.1. Company Overview
- 12.35.2. Financial Performance
- 12.35.3. Product Benchmarking
- 12.35.4. Recent Development
- 12.36. Bluebee
- 12.36.1. Company Overview
- 12.36.2. Financial Performance
- 12.36.3. Product Benchmarking
- 12.36.4. Recent Development
- 12.37. Repositive
- 12.37.1. Company Overview
- 12.37.2. Financial Performance
- 12.37.3. Product Benchmarking
- 12.37.4. Recent Development
- 12.38. Precision for Medicine
- 12.38.1. Company Overview
- 12.38.2. Financial Performance
- 12.38.3. Product Benchmarking
- 12.38.4. Recent Development
- 12.39. Shivom
- 12.39.1. Company Overview
- 12.39.2. Financial Performance
- 12.39.3. Product Benchmarking
- 12.39.4. Recent Development
- 12.40. Bluegnome
- 12.40.1. Company Overview
- 12.40.2. Financial Performance
- 12.40.3. Product Benchmarking
- 12.40.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.